AbbVie Inc. (ABBV)
NYSE: ABBV · IEX Real-Time Price · USD
166.42
+2.07 (1.26%)
At close: May 17, 2024, 4:00 PM
166.50
+0.08 (0.05%)
Pre-market: May 20, 2024, 9:02 AM EDT
AbbVie Market Cap
AbbVie has a market cap or net worth of $293.88 billion as of May 20, 2024. Its market cap has increased by 13.63% in one year.
Market Cap
293.88B
Enterprise Value
349.81B
1-Year Change
13.63%
Ranking
Category
Stock Price
$166.42
Market Cap Chart
Since January 2, 2013, AbbVie's market cap has increased from $55.49B to $293.88B, an increase of 429.61%. That is a compound annual growth rate of 15.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 293.88B | 1.26% |
May 16, 2024 | 290.22B | 0.34% |
May 15, 2024 | 289.23B | 1.36% |
May 14, 2024 | 285.35B | 0.19% |
May 13, 2024 | 284.80B | 0.33% |
May 10, 2024 | 283.86B | 0.22% |
May 9, 2024 | 283.25B | -0.03% |
May 8, 2024 | 283.33B | -1.29% |
May 7, 2024 | 287.04B | -0.11% |
May 6, 2024 | 287.36B | -0.65% |
May 3, 2024 | 289.23B | 1.82% |
May 2, 2024 | 284.07B | -0.56% |
May 1, 2024 | 285.67B | -0.57% |
Apr 30, 2024 | 287.30B | 0.69% |
Apr 29, 2024 | 285.32B | 1.19% |
Apr 26, 2024 | 281.96B | -4.58% |
Apr 25, 2024 | 295.51B | -0.30% |
Apr 24, 2024 | 296.41B | -1.03% |
Apr 23, 2024 | 299.49B | 0.98% |
Apr 22, 2024 | 296.57B | 0.89% |
Apr 19, 2024 | 293.96B | 1.06% |
Apr 18, 2024 | 290.87B | 0.25% |
Apr 17, 2024 | 290.14B | 1.05% |
Apr 16, 2024 | 287.12B | 0.54% |
Apr 15, 2024 | 285.59B | -0.38% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 731.34B |
Novo Nordisk | 585.45B |
UnitedHealth Group | 480.90B |
Johnson & Johnson | 371.45B |
Merck & Co. | 331.11B |
AstraZeneca | 238.18B |
Thermo Fisher | 226.57B |
Novartis AG | 201.19B |